An In Vitro Approach to Assess Intestinal Drug Metabolism and Transport
The epithelium of the small intestine provides a physical and biochemical banner that restricts the transcellular absorption of orally dosed drugs into the bloodstream through mechanisms including P-glycoprotein (Pgp) and Cytochrome P450 3A4 (CYP3A4). P-glycoprotein is constitutively expressed on th...
| Main Author: | |
|---|---|
| Published: |
University of Manchester
2007
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.493464 |
| id |
ndltd-bl.uk-oai-ethos.bl.uk-493464 |
|---|---|
| record_format |
oai_dc |
| spelling |
ndltd-bl.uk-oai-ethos.bl.uk-4934642015-03-20T05:16:12ZAn In Vitro Approach to Assess Intestinal Drug Metabolism and TransportEastwood, Martin2007The epithelium of the small intestine provides a physical and biochemical banner that restricts the transcellular absorption of orally dosed drugs into the bloodstream through mechanisms including P-glycoprotein (Pgp) and Cytochrome P450 3A4 (CYP3A4). P-glycoprotein is constitutively expressed on the apical membrane of the intestinal lumen where it can act to limit xenobiotic absorption by excreting drugs that have reached the cell interior back into the intestinal lumen. CYP3A4, the most abundant phase one drug metabolising enzyme in humans, can metabolise over fifty percent of commercially available drugs and is located apically within the enterocytes where it can restrict bioavailability by metabolising xenobiotics.615.7University of Manchesterhttp://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.493464Electronic Thesis or Dissertation |
| collection |
NDLTD |
| sources |
NDLTD |
| topic |
615.7 |
| spellingShingle |
615.7 Eastwood, Martin An In Vitro Approach to Assess Intestinal Drug Metabolism and Transport |
| description |
The epithelium of the small intestine provides a physical and biochemical banner that restricts the transcellular absorption of orally dosed drugs into the bloodstream through mechanisms including P-glycoprotein (Pgp) and Cytochrome P450 3A4 (CYP3A4). P-glycoprotein is constitutively expressed on the apical membrane of the intestinal lumen where it can act to limit xenobiotic absorption by excreting drugs that have reached the cell interior back into the intestinal lumen. CYP3A4, the most abundant phase one drug metabolising enzyme in humans, can metabolise over fifty percent of commercially available drugs and is located apically within the enterocytes where it can restrict bioavailability by metabolising xenobiotics. |
| author |
Eastwood, Martin |
| author_facet |
Eastwood, Martin |
| author_sort |
Eastwood, Martin |
| title |
An In Vitro Approach to Assess Intestinal Drug Metabolism and Transport |
| title_short |
An In Vitro Approach to Assess Intestinal Drug Metabolism and Transport |
| title_full |
An In Vitro Approach to Assess Intestinal Drug Metabolism and Transport |
| title_fullStr |
An In Vitro Approach to Assess Intestinal Drug Metabolism and Transport |
| title_full_unstemmed |
An In Vitro Approach to Assess Intestinal Drug Metabolism and Transport |
| title_sort |
in vitro approach to assess intestinal drug metabolism and transport |
| publisher |
University of Manchester |
| publishDate |
2007 |
| url |
http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.493464 |
| work_keys_str_mv |
AT eastwoodmartin aninvitroapproachtoassessintestinaldrugmetabolismandtransport AT eastwoodmartin invitroapproachtoassessintestinaldrugmetabolismandtransport |
| _version_ |
1716790266017349632 |